COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 2396: Articles 23951-23960  | Next

Inadequate level of knowledge, mixed outlook and poor adherence to COVID-19 prevention guideline among Ethiopians
Negera, E., Demissie, T. M., Tafess, K.
10.1101/2020.07.22.215590 — Posted: 2020-07-22
Elucidation of Genome Polymorphisms in Emerging SARS-CoV-2
Ray, M., Sarkar, S., Rath, S. N., Sable, M. N.
10.1101/2020.07.22.215731 — Posted: 2020-07-22
Virus-free and live-cell visualizing SARS-CoV-2 cell entry for studies of neutralizing antibodies and compound inhibitors
Zhang, Y., Wang, S., Wu, Y., Hou, W., Yuan, L., Sheng, C., Wang, J., Ye, J., Zheng, Q., Ma, J., Xu, J., Wei, M., Li, Z., Nian, S., Xiong, H., Zhang, L., Shi, Y., Fu, B., Cao, J., Yang, C., Li, Z., Yang, T., Liu, L., Yu, H., Hu, J., Ge, S., Chen, Y., Zhang, T., Zhang, J., Cheng, T., Yuan, Q., Xia, N.
10.1101/2020.07.22.215236 — Posted: 2020-07-22
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2
Ou, T., Mou, H., Zhang, L., Ojha, A., Choe, H., Farzan, M.
10.1101/2020.07.22.216150 — Posted: 2020-07-22
The discovery of a recombinant SARS2-like CoV strain provides insights into SARS and COVID-2019 pandemics
Li, X., Jin, X., Chen, S., Wang, L., Yau, T. O., Yang, J., Hong, Z., Ruan, J., Duan, G., Gao, S.
10.1101/2020.07.22.213926 — Posted: 2020-07-22
Rescue of SARS-CoV-2 from a single bacterial artificial chromosome
Ye, C., Park, J.-G., Oladunni, F., Platt, R. N., Anderson, T., Almazan, F., de la Torre, J. C., Martinez-Sobrido, L.
10.1101/2020.07.22.216358 — Posted: 2020-07-22
Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice
Yee, M., Cohen, E. D., Haak, J., Dylag, A. M., O'Reilly, M. A.
10.1101/2020.07.22.215962 — Posted: 2020-07-22
FDA approved calcium channel blockers inhibit SARS CoV 2 infectivity in epithelial lung cells
Straus, M. R., Bidon, M., Tang, T., Whittaker, G., Daniel, S.
10.1101/2020.07.21.214577 — Posted: 2020-07-22 Discussion: Onsite
The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner
Ogawa, J., Zhu, W., Tonnu, N., Singer, O., Hunter, T., Ryan (Firth), A. L., Pao, G. M.
10.1101/2020.07.21.214932 — Posted: 2020-07-22
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., Robbiani, D. F., Rice, C., Nussenzweig, M. C., Hatziioannou, T., Bieniasz, P. D.
10.1101/2020.07.21.214759 — Posted: 2020-07-22 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).